Effect of spironolactone on plasma brain natriuretic peptide and left ventricular remodeling in patients with congestive heart failure
- 作者Takayoshi Tsutamoto; Atsuyuki Wada; Keiko Maeda; Naoko Mabuchi; Masaru Hayashi; Takashi Tsutsui; Masato Ohnishi; Masahide Sawaki; Masanori Fujii; Takehiro Matsumoto; Toshiki Matsui; Masahiko Kinoshita
- 卷第37卷
- 期第5期
- 文件大小232.20KB
- 发表时间2001
- DOI10.1016/s0735-1097(01)01116-0
- 页码1228-1233
A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart DiseaseIung, B · European Heart Journal · 2003
MR of acquired heart disease: valvular heart diseaseGautham P. Reddy · 2001
Valvular heart disease associated with benfluorex therapy: high prevalence in patients with unexplained restrictive valvular heart diseaseBoudes, A.; Lavoute, C.; Avierinos, J.-F.; Le Dolley, Y.; Villacampa, C.; Salem, A.; Loundou, A. D.; Michel, N.; Renard, S.; Habib, G. · European Journal of Echocardiography · 2011
Decade in review—valvular disease: Current perspectives on treatment of valvular heart diseaseMohr, Friedrich W. · Nature Reviews Cardiology · 2014
Clinical Insights: Geriatric Valvular Disease || An overview of valvular heart disease in the elderlyPierard, Luc A · 2015
Valvular heart disease: Undiagnosed valvular involvement, concomitant coronary artery disease and systemic embolizationDonald E. Loew; Dwight E. Harken; Laurence B. Ellis · 1972
[Advances in Cardiology] Pathophysiology, Evaluation and Management of Valvular Heart Diseases Volume 39 || The Epidemiology of Valvular Heart Disease: An Emerging Public Health ProblemBorer, J.S.; Isom, O.W. · 2002
[Advances in Cardiology] Pathophysiology, Evaluation and Management of Valvular Heart Diseases, Vol. 2 Volume 41 || The Epidemiology of Valvular Heart Diseases: The Problem Is GrowingBorer, J.S.; Isom, O.W. · 2004
Calcified rheumatic heart valves are associated with osteopontin bone matrix expressionNalini M. Rajamannan; Trisha Smith; Lisa Nee; Thomas J. Sebo; Raffay Khan; Robert H. Bonow; James Fredrickson; David Fullerton; A. Jamil Tajik; Robert O. Bonow · 2003
Atorvastatin decreases cellular proliferation and bone matrix expression in the hypercholesterolemic mitral valveBabu Makkena; Hani Salti; Malayannan Subramaniam; Senthil Thennapan; Robert H. Bonow; Frank Caira; Robert O. Bonow; Thomas C. Spelsberg; Nalini M. Rajamannan · 2005
Atrovastatin improves an atherosclerotic and proliferative lesion on the mitral valve induced by experimental hypercholesterolemiaNalini M. Rajamannan; Hani I. Salti; Raffay Khan; Robert H. Bonow; Sameer Gupta; Parag Jain; Nell Stone; Robert O. Bonow · 2002
Myocardial viabilityRobert C. Hendel; Farooq A. Chaudhry; Robert O. Bonow · 1996
Author Relationships With IndustryYancy, Clyde W.; Harrington, Robert A.; Bonow, Robert O. · JAMA Cardiology · 2017
Symposium PresentationsMichael E. Mendelsohn; C. William Balke; Robert O. Bonow; Valentin Fuster; Augustus O. Grant; Daniel B. Mark; Eric D. Peterson; Elliott M. Antman; Harlan M. Krumholz; Robert S. Balaban; Eric N. Prystowsky; James J. Ferguson; Thabet O. Al-Sheikh; Bradford C. Berk; Stephen F. Vatner; Douglas P. Zipes; David R. Holmes Jr; Christine E. Seidman; Elizabeth G. Nabel; William A. Zoghbi · 2005
A report of the American Society of Nuclear Cardiology Task Force on Women and Heart Disease (writing group on perfusion imaging in women)Jennifer H. Mieres; Leslee J. Shaw; Robert C. Hendel; D.Douglas Miller; Robert O. Bonow; Daniel S. Berman; Gary V. Heller; Jennifer H. Mieres; C.Noel Bairey-Merz; Daniel S. Berman; Robert O. Bonow; Jean M. Cacciabaudo; Gary V. Heller; Robert C. Hendel; Maria C. Kiess; D.Douglas Miller; Donna M. Polk; Leslee J. Shaw; Paola E. Smanio; Mary N. Walsh · 2003
Platypnea and interatrial right-to-left shunting after lobectomyRobert M. Springer; Mihai Gheorghiade; C.Simon Chakko; George M. Bell; Richard O. Cannon III; Joann Urquhart; Michael Jones; Robert O. Bonow · 1983